The influence of adenine on the clinical features and purine metabolism in the Lesch-Nyhan syndrome.
D000225:Adenine / Q000627:therapeutic use*; D000493:Allopurinol / Q000627:therapeutic use; D001264:Athetosis / Q000235:genetics; D001853:Bone Marrow / Q000473:pathology; D002247:Carbon Isotopes; D002648:Child; D002675:Child, Preschool; D002819:Chorea / Q000235:genetics; D003192:Compulsive Behavior; D004035:Diet Therapy; D004912:Erythrocytes / Q000032:analysis; D005492:Folic Acid / Q000627:therapeutic use; D005998:Glycine / Q000378:metabolism; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D008297:Male; D008661:Metabolism, Inborn Errors / Q000150:complications / Q000188:drug therapy* / Q000235:genetics*; D009069:Movement Disorders / Q000150:complications; D011687:Purines / Q000096:biosynthesis / Q000378:metabolism*; D012652:Self Mutilation / Q000150:complications; D014166:Transferases / Q000097:blood; D014527:Uric Acid / Q000097:blood* / Q000652:urine; D014805:Vitamin B 12 / Q000627:therapeutic use
D002247:Carbon Isotopes; D011687:Purines; D014527:Uric Acid; D000493:Allopurinol; D005492:Folic Acid; D014166:Transferases; D000225:Adenine; D014805:Vitamin B 12; D005998:Glycine